insights_auto
Why is VRAX down 3,37%?
Dive Deeperchevron_right
VRAX:NASDAQ
Virax Biolabs Group Ltd
US$2,31
arrow_downward
-3,37%(-0,081) 1D
28 ກ.ຍ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRAX...
Open
US$2,35
High
US$2,35
Low
US$2,30
Mkt. cap
3,06 ລ້ານ
Avg. vol.
660,02 ພັນ
Volume
0,00
52-wk high
US$21,75
52-wk low
US$2,18
EPS
US$-12,64
Beta
1,37
Shares outstanding
1,34 ລ້ານ
No. of employees
26
Open
US$2,35
High
US$2,35
Low
US$2,30
Mkt. cap
3,06 ລ້ານ
Avg. vol.
660,02 ພັນ
Volume
0,00
52-wk high
US$21,75
52-wk low
US$2,18
EPS
US$-12,64
Beta
1,37
Shares outstanding
1,34 ລ້ານ
No. of employees
26
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 ເດືອນກ່ອນ
Virax Biolabs (VRAX) Advances 1.42% to $2.86 as Biotech Diagnostics Names Hold Support - NHNL Ratio
About Virax Biolabs Group Ltd
CEO-
Employees26
Founded2013
Headquartersລອນດອນ, ປະເທດອັງກິດ, ສະຫະລາດຊະອະນາຈັກ
SectorHealth care provider
Websiteviraxbiolabs.com